Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Efficacy Of Beta-lapachone In Pancreatic Cancer Treatment: Exploiting The Novel, Therapeutic Target NQO1
Matthew Ough, A. Lewis, E. Bey, J. Gao, J. Ritchie, W. Bornmann, D. Boothman, L. Oberley, J. Cullen
Published 2005 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
NAD(P)H:quinone oxidoreductase (NQO1) is elevated in human pancreatic cancers. We hypothesized that £]-lapachone, a novel 1,2-naphthoquinone with potential antitumor activity in cancer cells expressing elevated levels of NQO1, would induce cytotoxicity in pancreatic cancer cells, wherein this two-electron reductase was recently found elevated. ?-lapachone decreased clonogenic cell survival, metabolic cell viability, and anchorage-independent growth in soft agar. The cytotoxic in vitro effects of ?- lapachone were inhibited with co-administration of dicumarol, a specific inhibitor of NQO1. In pre-established human pancreatic tumor xenografts in nude mice, ?-lapachone demonstrated greater tumor growth inhibition when given intratumorally compared to when complexed with cyclodextrin to increase its bioavailability. Due to the poor prognosis of patients with pancreatic cancer and the limited effectiveness of surgery, chemotherapy, and radiation therapy, treatment regimens based on sound, tumor-specific rationales are desperately need for this disease.
This paper references
Upregulation of the plasma membrane oxidoreductase as a prerequisite for the viability of human Namalwa ρ ̊ cells
JA Larm (1994)
Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.
T. Loftsson (1996)
Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism.
J. Cullen (2003)
Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase.
C. Weydert (2003)
Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery.
R. Rajewski (1996)
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
H. Burris (1997)
Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
C. Logsdon (2003)
Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response.
S. Planchon (1995)
Effect of beta-lapachone on hydrogen peroxide production in Trypanosoma cruzi.
F. Cruz (1978)
Enhancement of Solubility and Bioavailability of β-Lapachone Using Cyclodextrin Inclusion Complexes
N. Nasongkla (2004)
Up-regulation of the plasma membrane oxidoreductase as a prerequisite for the viability of human Namalwa rho 0 cells.
J. Larm (1994)
Pharmaceutical applications of cyclodextrins
T Irie (1997)
Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation.
T. Irie (1997)
Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-κB in malignant melanoma cells
S. Brar (2001)
Information Theory and an Extension of the Maximum Likelihood Principle
H. Akaike (1973)
Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: combining drugs imposes different artificial checkpoints.
C. Li (1999)
Pharmaceutical applications of cyclodextrins
RA Rajewski (1996)
Trypanosoma cruzi: ultrastructural and metabolic alterations of epimastigotes by beta-lapachone.
R. Docampo (1977)
Trypanosoma cruzi: Ultrastructual and metabolic alterations of epimastigotes by β-lapachone
R Docampo (1977)
Treatment of Pancreatic Cancer Cells with Dicumarol Induces Cytotoxicity and Oxidative Stress
Anne Lewis (2004)
Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues.
D. Siegel (2000)
NAD(P)H:Quinone Oxidoreductase Activity Is the Principal Determinant of β-Lapachone Cytotoxicity*
J. Pink (2000)
Cyclodextrins: Their Future in Drug Formulation and Delivery
V. Stella (2004)
Beta-lapachone, a specific competitive inhibitor of ligand binding to the glucocorticoid receptor.
T. Schmidt (1984)
Analysis of target cell susceptibility as a basis for the development of a chemoprotective strategy against benzene-induced hematotoxicities.
M. Trush (1996)
Immunodetection of NQO1 in human tissues
D Siegel (2000)
Cancer Statistics, 2002
A. Jemal (2002)
This paper is referenced by
Antibacterial and antioxidant activities for natural and synthetic dual-active compounds.
G. Martelli (2018)
Synthesis of naturally occurring naphthoquinone epoxides and application in the synthesis of beta-lapachone.
S. Claessens (2010)
The encapsulation of β-lapachone in 2-hydroxypropyl-β-cyclodextrin inclusion complex into liposomes: a physicochemical evaluation and molecular modeling approach.
I. M. Cavalcanti (2011)
Compatibility of the antitumoral beta-lapachone with different solid dosage forms excipients.
M. S. S. Cunha-Filho (2007)
Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis
Qiqing Sun (2020)
Biotransformação da B-lapachona utilizando culturas microbianas: uma alternativa para estudos de metabolismo in vitro
C. R. Paludo (2013)
Synthesis of 2-amino-3-cyano-4H-chromen-4-ylphosphonates and their anticancer properties.
Reddi Mohan Naidu Kalla (2014)
Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction
Yongqing Han (2019)
Mornings with art, lessons learned: Feedback regulation, restriction threshold biology, and redundancy govern molecular stress responses
E. Bey (2006)
NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells.
Nalinee Pradubyat (2019)
Synthesizing Substituted 2-Amino-2-chromenes Catalyzed by Tertiaryamine-Functionalized Polyacrylonitrile Fiber for Students To Investigate Multicomponent Reactions and Heterogeneous Catalysis
Yujia Xie (2016)
Synthesis of a 1,2,3-bistriazole derivative of embelin and evaluation of its effect on high-fat diet fed-streptozotocin-induced type 2 diabetes in rats and molecular docking studies.
A. Stalin (2020)
Synthesis of tricyanomethanesulfonic acid as a novel nanostructured and recyclable solid acid: application at the synthesis of biological henna-based chromenes
M. A. Zolfigol (2017)
A Green, Organometallic Catalyzed Synthesis of a Series of Novel Functionalized 4-Aroyl-4H-benzo[g]chromenes through One-pot, Three Component Reaction: Synthesis of 4-Aroyl-4H-benzo[g]chromenes
J. Khalafy (2018)
The trypanocidal activity of naphthoquinones: a review.
A. V. Pinto (2009)
Caracterização físico-química do potencial agente antineoplásico β-lapachona
José Lourenço Freitas-Neto (2013)
Efficient one-pot synthesis of β-phosphono malonates and 2-amino-4H-chromen-4-ylphosphonate derivatives by ethylenediamine diacetate-catalyzed three-component reactions
Srinivasa Rao Kolla (2012)
Anti-inflammatory and anti-arthritic activities of 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione (β-lapachone)
Marília Maria Sitônio (2012)
Mechanism of action of novel naphthofuranquinones on rat liver microsomal peroxidation.
Igal Elingold (2009)
Choline chloride based eutectic solvent for the efficient synthesis of 2-amino-4H-chromen-4-yl phosphonate derivatives via multicomponent reaction under mild conditions
Suresh Kumar Krishnammagari (2018)
Synthesis of 2-amino-3-cyano-4H-chromen-4-ylphosphonates and 2-amino-4H-chromenes catalyzed by tetramethylguanidine
Reddi Mohan Naidu Kalla (2013)
One-Pot Synthesis of Some2-Amino-4H-benzo[g]chromenes
B. Maleki (2016)
The chemotherapeutic effects of lapacho tree extract: Î²-lapachone
Hsiu-Ni Kung (2014)
New Crown Ether-Based Ionic Liquids as a Green and Versatile Organocatalyst for Three-Component Synthesis of 1,5-Dihydropyrano[2,3- c]chromene Derivatives
Iman Mohammadzadeh (2020)
Novel o-naphthoquinones induce apoptosis of EL-4 T lymphoma cells through the increase of reactive oxygen species.
M. E. Di Rosso (2013)
Intermolecular Interactions between Coencapsulated Drugs Inhibit Drug Crystallization and Enhance Colloidal Stability of Polymeric Micelles.
L. Zhang (2017)
Integrated block copolymer prodrug nanoparticles for combination of tumor oxidative stress amplification and ROS-responsive drug release.
W. Yin (2019)
Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line.
E. Pérez-Sacau (2007)
β-Lapachone Induces Acute Oxidative Stress in Rat Primary Astrocyte Cultures that is Terminated by the NQO1-Inhibitor Dicoumarol
Johann Steinmeier (2020)
Zn( L‐proline)2 as a powerful and reusable organometallic catalyst for the very fast synthesis of 2‐amino‐4H‐benzo[g]chromene derivatives under solvent‐free conditions
B. Maleki (2015)
Aqueous microwave-assisted DMAP catalyzed synthesis of β-phosphonomalonates and 2-amino-4H-chromen-4-ylphosphonates via a domino Knoevenagel-phospha-Michael reaction
P. Kour (2017)
An eco-friendly sequential catalyst- and solvent-free four-component stereoselective synthesis of novel 1,4-pyranonaphthoquinones
B. D. Bala (2012)See more